A Study to Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sphingomyelinase Deficiency (ASMD) Who Completed the DFI12712 or the LTS13632 Study in France

NCT06949358 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
3
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi